These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30915713)

  • 41. Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?
    Soutar MP; Thornhill P; Cole AR; Sutherland C
    Curr Alzheimer Res; 2009 Jun; 6(3):269-78. PubMed ID: 19519308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus.
    Wang X; Yu Y; Ma R; Shao N; Meng H
    Neuroreport; 2018 Nov; 29(16):1384-1390. PubMed ID: 30169428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility.
    Fazil MHUT; Prasannan P; Wong BHS; Kottaiswamy A; Salim NSBM; Sze SK; Verma NK
    Front Immunol; 2021; 12():680071. PubMed ID: 34975828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.
    Rahajeng J; Giridharan SS; Naslavsky N; Caplan S
    J Biol Chem; 2010 Oct; 285(42):31918-22. PubMed ID: 20801876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of Adipogenesis and Lipid Deposits by Collapsin Response Mediator Protein 2.
    Chang YH; Tsai JN; Chang SW; Hsu WT; Yang CP; Hsiao CW; Shiau MY
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K; Matsuura K; Nakamura-Hirota T; Takano M; Otani M; Matsuyama S
    J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration.
    Varrin-Doyer M; Vincent P; Cavagna S; Auvergnon N; Noraz N; Rogemond V; Honnorat J; Moradi-Améli M; Giraudon P
    J Biol Chem; 2009 May; 284(19):13265-76. PubMed ID: 19276087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
    Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
    Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury.
    Moutal A; Ji Y; Bellampalli SS; Khanna R
    Mol Brain; 2020 Jun; 13(1):97. PubMed ID: 32571373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PKCγ-Mediated Phosphorylation of CRMP2 Regulates Dendritic Outgrowth in Cerebellar Purkinje Cells.
    Winkler SC; Shimobayashi E; Kapfhammer JP
    Mol Neurobiol; 2020 Dec; 57(12):5150-5166. PubMed ID: 32860158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration.
    Morales X; Peláez R; Garasa S; Ortiz de Solórzano C; Rouzaut A
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
    Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
    Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.
    Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB
    Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
    Hensley K; Kursula P
    J Alzheimers Dis; 2016 Apr; 53(1):1-14. PubMed ID: 27079722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
    Lin B; Li Y; Wang T; Qiu Y; Chen Z; Zhao K; Lu N
    Oncogene; 2020 Sep; 39(37):6024-6040. PubMed ID: 32778769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes.
    Ricard D; Rogemond V; Charrier E; Aguera M; Bagnard D; Belin MF; Thomasset N; Honnorat J
    J Neurosci; 2001 Sep; 21(18):7203-14. PubMed ID: 11549731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief.
    Moutal A; Shan Z; Miranda VG; François-Moutal L; Madura CL; Khanna M; Khanna R
    Channels (Austin); 2019 Dec; 13(1):498-504. PubMed ID: 31680630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRMP2 tethers kainate receptor activity to cytoskeleton dynamics during neuronal maturation.
    Marques JM; Rodrigues RJ; Valbuena S; Rozas JL; Selak S; Marin P; Aller MI; Lerma J
    J Neurosci; 2013 Nov; 33(46):18298-310. PubMed ID: 24227739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling.
    Garza JC; Qi X; Gjeluci K; Leussis MP; Basu H; Reis SA; Zhao WN; Piguel NH; Penzes P; Haggarty SJ; Martens GJ; Poelmans G; Petryshen TL
    Transl Psychiatry; 2018 Jul; 8(1):135. PubMed ID: 30046097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.